A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer

NCT07083505 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: HB1801
DRUG: Taxotere®

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.